Aksan has advised PhiTech Bioinformatics on a new investment round.
NKO Advises Dr. Max Group on Fourth Pharmacy Chain Acquisition in 2023
NKO Partners has advised the Dr. Max Group on its acquisition of the Vranje-based Nova Pharm pharmacy chain in Serbia.
Gessel Advises Urteste on New Share Public Offering and Switch to WSE Regulated Market
Gessel has advised Urteste on the public offering of its new share issuance and switching its market listing from the ASO NewConnect to the regulated market of the Warsaw Stock Exchange.
Aksan Advises Medicover on Acquisition of Guven Lab
Aksan has advised the Medicover Group on the acquisition of Guven Laboratuvarlari from founder Ahmet Sahin. BeyKem reportedly advised Ahmet Sahin on the deal.
KLC Advises GAP Pharmaceutical on Business Agreement with Innovis Pharma
The KLC Law Firm has advised GAP Pharmaceutical Products on transferring its Greek market-approved pharmaceutical licenses to Innovis Pharma.
SK&S Advises AniCura on Wroblewscy Partnership
Soltysinski Kawecki & Szlezak has advised veterinary clinic chain AniCura on its partnership with the Wroblewscy veterinary clinic in Dabrowa Gornicza, Poland. Roedl & Partner reportedly advised AniCura as well.
Michal Tracz Makes Partner at KRK Kieszkowska Rutkowska Kolasinski
Former Senior Associate Michal Tracz has been promoted to a Partner position at KRK Kieszkowska Rutkowska Kolasinski in Warsaw.